Anders Fink-Jensen
Clinical Professor
- 2023
- Published
Effect of the GLP-1 receptor agonist semaglutide on metabolic disturbances in clozapine-treated or olanzapine-treated patients with a schizophrenia spectrum disorder: study protocol of a placebo-controlled, randomised clinical trial (SemaPsychiatry)
Sass, M. R., Danielsen, A. A., Köhler-Forsberg, O., Storgaard, H., Knop, Filip Krag, Nielsen, Mette Ødegaard, Sjödin, Anders Mikael, Mors, O., Correll, C. U., Ekstrøm, Claus Thorn, Vinberg, Maj, Nielsen, Jimmi, Vilsbøll, Tina & Fink-Jensen, Anders, 2023, In: BMJ Open. 13, 1, 10 p., e068652.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
GLP-1 receptor agonists are promising but unproven treatments for alcohol and substance use disorders
Leggio, L., Hendershot, C. S., Farokhnia, M., Fink-Jensen, Anders, Klausen, M. K., Schacht, J. P. & Simmons, W. K., 2023, In: Nature Medicine. 29, 12, p. 2993-2995 3 p.Research output: Contribution to journal › Comment/debate › Research › peer-review
- Published
Semaglutide for the treatment of antipsychotic-associated weight gain in patients not responding to metformin - a case series
Prasad, F., De, R., Korann, V., Chintoh, A. F., Remington, G., Ebdrup, Bjørn, Siskind, D., Knop, Filip Krag, Vilsbøll, Tina, Fink-Jensen, Anders, Hahn, M. K. & Agarwal, S. M., 2023, In: Therapeutic Advances in Psychopharmacology. 13, 10 p., 20451253231165169.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
The effectiveness of oxytocin for treating substance use disorders: A systematic review of randomized placebo-controlled trials
Mellentin, A. I., Finn, S. W., Skøt, L., Thaysen-Petersen, D., Mistarz, N., Fink-Jensen, Anders & Nielsen, D. G., 2023, In: Neuroscience and Biobehavioral Reviews. 151, 16 p., 105185.Research output: Contribution to journal › Review › Research › peer-review
- Published
The use of classic psychedelics among adults: a Danish online survey study
Søgaard Juul, T., Ebbesen Jensen, M. & Fink-Jensen, Anders, 2023, In: Nordic Journal of Psychiatry. 77, 4, p. 367-378Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Virtual reality-assisted cognitive behavioural therapy for outpatients with alcohol use disorder (CRAVR): A protocol for a randomised controlled trial
Thaysen-Petersen, D., Hammerum, S. K., Vissing, A. C., Arnfred, B. T., Nordahl, R., Adjorlu, A., Nordentoft, Merete, Oestrich, I. H., Düring, S. W. & Fink-Jensen, Anders, 2023, In: BMJ Open. 13, 3, e068658.Research output: Contribution to journal › Journal article › Research › peer-review
ID: 916366
Most downloads
-
5759
downloads
Increased systemic oxidatively generated DNA and RNA damage in schizophrenia
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
222
downloads
Asymmetric dimethylarginine in somatically healthy schizophrenia patients treated with atypical antipsychotics: a case-control study
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
158
downloads
Psychiatric disease as a risk factor in fast-track hip and knee replacement: An overview of the literature
Research output: Contribution to journal › Review › Research › peer-review
Published